Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist
Autor: | Sen, S., Chen, S., Feng, B., Iglarz, M., Chakrabarti, S. |
---|---|
Zdroj: | In Life Sciences 15 October 2012 91(13-14):658-668 |
Databáze: | ScienceDirect |
Externí odkaz: |